A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models

Overview of attention for article published in Diabetologia, November 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,447 followers.

Vaccine against CSV reveals no risk for accelerated diabetes in NOD http://t.co/4aRzUdGpVW

Coxsackievirus B1 vaccine: no risk for accelerated diabetes development in mouse models http://t.co/vlctbjM9dz Larsson &al Diabetologia